kinds of products which have Rf 0.9 (Product I) and 0.1 (Product II), respectively, on silica gel thin-layer chromatography developed with benzene -dioxane -acetic acid (10: 5: 1). Each product was found to be a mixture of two fatty acid methyl esters (Product I, 5a and 5b) and two acyl peptides (Product II, 6a and 6b) respectively (Scheme 1). GC-MS analysis of product I demonstrated that it consists of two compounds in the ratio of ca. 1: 1, and their molecular weight are 256 (5a, retention time: 7 minutes) and 254 (5b, retention time: 7.8 minutes). By catalytic hydrogenation over 10% Pd-C, the mixture (5a and 5b) converged to the former (5a), which was identified as methyl 13-methyltetradecanoate by comparison of the authentic THE JOURNAL OF ANTIBIOTICS NOV. 1985 sample synthesized from 10-bromodecanoic acid via three steps (see Experimental). Therefore, the latter compound (5b) must be the dehydro-compound of 5a. The presence and position of the double bond in 5b were established as follows. Oxidation of the mixture (Product I) with osmium tetroxide afforded a i-lactone [7, Cl5H23O3 (M+ 256) ; NMR (CDCl3) 6 3.90 (1H, m), 4.45 (1H, m) ; IR (CHCl3)
1765 cm-1], and with m-chloroperbenzoic acid an epoxide (8). The analysis of the fragment peaks in the EI-MS of 8 ( Fig. 1 ),3' unequivocally determined the latter fatty acid methyl ester (5b) to be methyl 13-methyl-4-tetradecenoate. The foregoing experimental results suggested that WB-3559 A
(1) and B (2) possess 13-methyl-4-tetradecenoic acid moiety, while WB-3559 C (3) and D (4) 13-methyltetradecanoic acid moiety in those molecules respectively.
On the other hand, product II obtained by methanol ysis of WB-3559 was assumed to be a mixture of two compounds from its FD mass spectral data [6a: m/z 453 (M++Na), n=11; 6b: m/z 439 (M+-;-Na), n=10]. Acid hydrolysis (6 N HCl, 100°C, 20 hours) of product II (6a and 6b) yielded glycine and serine (1: 1), which were characterized by conventional amino acid analysis.
After the hydrolysate was extracted with ethyl acetate, the residual aqueous solution was lyo- In order to disclose the unknown structure of the acyl part in WB-3559, structure analysis was focused on the isolated component: WB-3559 D (4). 4 was transformed into the acetyl methyl ester derivative (9) by methylation with diazomethane followed by treatment with acetic anhydride in pyridine.
In the 1H NMR spectrum (100 MHz, CDCl3, Fig. 2 ) of 9, irradiation of a triplet triplet signal (.Ha) at o 5.20 (1H, J=6, 6 Hz) caused the decoupling of a doublet signal (Hr) at 5 2.54 (2H, J=6 Hz) into a sin.-let, indicating the presence of acyloxyacyl unit in the molecule of 9. Further analysis of the `H NMR spectrum of 9 assisted by double resonance technique led to the assignments of all the signals as shown in Table 1 .
The sequence of the ;53-acyloxyacyl unit, glycine and L-serine in the structure of WB-3559 D (4) was elucidated by analysis of the El-MS of its methyl ester (13), derived from 4 on treatment with diazomethane. The structures of the other three components: WB-3559 A, B and C were clarified by the comparison of the mass fragment peaks in the EI-MS of their respective methyl esters 10, 11 and 12 with those of 13. Table 2 shows the assignment of each fragment peak, which is in good agreement with the corresponding chemical structures shown.
The foregoing experimental data and discussions enabled us to deduce the structures of WB-3559 
THE JOURNAL OF ANTIBIOTICS tive 21, and then acylation of 21 with 13-methyltetradecanoyl chloride was effected to give 22 (overall yield 64% from 20). 13-Methyltetradecanoic acid') was synthesized as follows: (1) Wittig condensation of isobutyraldehyde and 10-carboxydecyltriphenylphosphorane in DMSO-THF, 56% yield, (2) hydrogenation over Pd-black at 3.5-4.0 atm, 84% yield. After hydrogenation of 22 over Pd-black in acetic acid, the resulting N-acylglycine 23 was finally coupled with L-serine by active ester procedure
+19.5° (c 0.3, CHCl3), which was all identical with the natural WB-3559 D.1)
The total synthesis of WB-3559 D thus achieved, disclosed the (R) configuration of the assymetric center in the acyl part of the natural product (4) .
The analogy of the [a]D values among WB-3559
A, B, C and D allowed the assignment of the absolute configurations in the acyl part of these four natural products to be all (R) configuration.
Experimental
The IR spectra were recorded with a Jasco IRA-2 spectrophotometer. 1H NMR spectra were measured on a Jeol PMX-60 or a Jeol PS-100 spectrophotometer, and chemical shifts are given on the 8 (ppm) scale with tetramethylsilane as an internal standard (s, ringlet; d, doublet; t, triplet; br, broad; m, multiplet). EI-MS and FD-MS spectra were recorded using a Hitachi M-80 mass spectrometer and a Jeol JMS-D-300 mass spectrometer, respectively. Melting points were measured with a Yanagimoto microscope hot-stage apparatus and are uncorrected. Preparative thin-layer chromatography (TLC) was carried out on a Merck Silica gel F254 pre-coated plate, Art 5744.
Catalytic Hydrogenation of WB-3559
A solution of WB-3559 (10 mg) in MeOH (2 ml) was hydrogenated over 10%. Pd-C (10 mg) under H2 at atmospheric pressure. After removal of the catalyst by filtration, the filtrate was evaporated to give a residue (9 mg), which was subjected to liquid chromatography on the conditions used in the preceding paper,1) showing that the products contain WB-3559 C and D in the ratio of 1: 4.
Methanolysis of WB-3559
To a solution of in MeOH (8 ml) was added a solution of 28 % CH3ONa in MeOH (150 yl) and the resulting solution was stirred at room temp for 2 hours. The reaction mixture was poured into ice water and the mixture was acidified with 1 N HCl, extracted with EtOAc and ether. The extracts were combined, washed with H2O, dried over MgSO4 and evaporated to dryness in vacuo. The residue was purified by preparative TLC, eluted with a mixture of benzene -dioxaneacetic acid (10: 5: 1) to give product I (oil, Rf 0.9, 62 mg) and product II (powder, Rf 0.1, 109 mg).
GC-EI-MS of product I showed that it consists of two compounds in the ratio of ca. 1: 1, and their molecular weights are 256 (5a, retention time: 7 minutes) and 254 (5b, retention time: 7.8 minutes).
The GC-MS conditions are as follows. Instrument: Shimadzu QP 1000. Capillary column GC column: fused silica ULBON HR-52 (0.32 mm i.d. x 25 m); temperatures: column 160°C isothermal, injector 220°C; carrier gas: He, 1 ml/minute. MS ion source temp: 250°C, separator temp: 250°C; electron energy: 20 eV.
The product II was shown to be a mixture of two acyl peptides (6a and 6b) from the following physical data: IR ( Catalytic Hydrogenation of the Mixture of 5a and 5b The mixture (9 mg) of 5a and 5b obtained by methanolysis of WB-3559, was dissolved in a mixture of MeOH (1 ml) and EtOAc (1 ml). This solution was hydrogenated over 10% Pd-C (10 mg) under H2 at atmospheric pressure for 5 hours. After removal of the catalyst by filtration, the filtrate was evaporated to give a residue, which was purified by preparative TLC, developed with a mixture of r-Lactone (7) The mixture (30 mg) of 5a and 5b obtained by methanolysis of WB-3559, was dissolved in ether (2 ml). To this solution was added OsO, (25 mg), and the mixture was stirred at room temp under a nitrogen atmosphere overnight. After removal of the solvent, the black residue was dissolved in pyridine (1 ml), and then a solution of NaHSO, (140 mg) in H,O (1 ml) was added. The resulting mixture was stirred at room temp for 5 hours, followed by addition of H,O (10 ml) and by extraction with EtOAc (10 ml x 2). The EtOAc solution was washed with dil HCl, H,O and dried over MgSO4 and then evaporated in vacuo to give a residue (29 mg), which was purified by preparative TLC, eluted with MeOH -CHCl3 (1: 20) to afford 7 (10 mg) and 5a (14 mg) as oils. 
Epoxide 8
The mixture (20 mg) of 5a and 5b obtained by methanolysis of WB-3559, was dissolved in CH2Cl, (1 ml). To this solution was added m-chloroperbenzoic acid (18 mg) and the resulting mixture was stirred at room temp for 3 hours. The reaction mixture was poured into H,O (10 ml) and extracted with CHCl3 (10 ml x 2). The CHCl3 solution was washed with aq NaHCO" H2O, dried over MgSO, and evaporated to dryness. The residue was purified by preparative TLC, eluted with ether -heptane (3: 7) to afford 8 (6 mg) and 5a (9 mg) as oils. Acid Hydrolysis of the Mixture of 6a and 6b The mixture (45 mg) of 6a and 6b obtained by methanolysis of WB-3559, was dissolved in 6 N HCl (7 ml). The resulting solution was heated at 100°C for 21 hours. After cooled, the solution was diluted with H,O (20 ml) and extracted with EtOAc (15 ml x 2). The residual aqueous solution was lyophilized to give a residue (15 mg), which was shown to contain glycine and serine (ca. 1: 1) by amino acid analysis. This residue was dissolved in I N NaOH (1 ml) and then carbobenzoxy chloride (100 mg) was added at 0°C. After the resulting mixture was stirred at 0°C for 3 hours, the reaction mixture was poured into ice water, and extracted with ether to remove excess carbobenzoxy chloride. The residual aqueous solution was acidified with I N HCl, extracted with EtOAc, washed with brine, and evaporated to dryness. The residue (14 mg) was purified by preparative TLC, eluted with EtOAc -CHCl3 (1: 4) to give Z-Gly-OMe (5 mg) and Z-L-Ser-OMe (6 mg), which were all identical with those of authentic samples.
Z-Gly-OMe: NMR (CDCl3) Acetyl Methyl Ester Derivative (9) of WB-3559 D A solution of 13 (12 mg) and Ac,O (0.5 ml) in pyridine (1 ml) was allowed to stand overnight at room temp. The reaction mixture was evaporated off using high vacuum pump to give a residue (14 mg), which was purified by preparative TLC, eluted with acetone -CHCl3 (1: 9) to afford the acetyl methyl ester derivative (9, 13 mg) of WB-3559 D as an oil: NMR, see Table 1 ; EI-MS m/z 710 (M+).
I1-Methyldodecyl Chloride
A mixture of 1,10-dichlorodecane (32 g), Nal (23 g) and acetone (200 ml) was refluxed for 4 hours. The cooled mixture was filtered to remove the resultant NaCl and the filtrate was evaporated under reduced pressure. To the residue was added H,O (100 ml) and the mixture was extracted with ether (50 ml x 2). The extracts were washed with aq Na2S2O3, H20 and then dried over MgSO4. After removal of the solvent, the residual oil was distilled under reduced pressure to give 1-chloro-10-iododecane (12 g, by 140°C/2.5 mm) as a colorless oil.
To a suspension of Mg (1 g) in dry THE (20 ml) was added isopropyl chloride (3.6 ml), and the mixture was refluxed for 30 minutes. After cooled, the resulting Grignard reagent was slowly added to a stirred solution of 1-chloro-10-iododecane (12 g), LiCl (68 mg) and CuCl2 (54 mg) in THE (20 ml) at 5°C. The mixture was stirred at the same temp for 1 hour under argon atmosphere, and poured into ice-water, and then extracted with ether. The organic solution was washed with 1 N HCl, water and dried over MgSO4. Removal of the solvent gave an oil, which was distilled under reduced pressure to afford 11-methyldodecyl chloride (5 g) as a colorless oil: by 106°C/0.6 mm; NMR (CDCl3) v 0.86 (6H, d, J-7 Hz), 1.20-1.80 (19H, m) , 3.52 (2H, t, J=7 Hz).
11-Methyldodecyltriphenylphosphonium Chloride (15)
A mixture of 11-methyldodecyl chloride (2.32g) and triphenylphosphine (2.8g) was heated at 140°C for 12 hours. After cooled, the resulting solid was triturated with benzene and then ether to give a powder of I1-methyldodecyltriphenylphosphonium chloride (4.5 g), which was used for the next Wittig reaction without further purification.
(3aR,5S,6aR)-2,2-Dimethyl-5-(12-methyl-l-tridecenyl)furo- [2,3-d] [1, 3] dioxole (16) To a solution of I 1-methyldodecyltriphenylphosphonium chloride (2 g) in anhydrous THE (30 ml), was added a solution (2.6 ml, 1.56 M solution) of n-butyllithium in n-hexane slowly, and the resulting red-orange solution was stirred at room temp for 1 hour under dry nitrogen atmosphere. To this solution was added a freshly prepared solution of 1,2-O-isopropylidene-3-deoxy-D-erythro-pentodialdofuranose4) (693 mg) in anhydrous THE (5 ml), and the mixture was stirred at ambient temp for 30 minutes and then at 50°C for 5 minutes under dry nitrogen atmosphere. After the solvent of the reaction mixture was removed, H2O (30 ml) was added to the residue and the mixture was extracted THE JOURNAL OF ANTIBIOTICS NOV. 1985 with n-pentane (20 ml x 2). The extract was washed with brine, dried over MgSO, and evaporated to leave an oil, which was chromatographed on silica gel, eluted with CHCl3 to give cis and trans mixture of 16 (0.88 g) as an oil: IR (CHCl3) 2920, 2850, 1650, 1460, 1380, 1370, 1160, 1060, 1040, 1010 (3aR,5S,6aR)-2,2-Dimethyl-5-(12-methyltridecyl)furo- [2,3- 
A solution of 16 (0.78 g) in EtOH (20 ml) was hydrogenated over PtO2 (0.3 g) under H2 at atmospheric pressure for 3 hours. After removal of the catalyst by filtration, the filtrate was evaporated to leave an oil, which was chromatographed on silica gel, eluted with CHCl3 to give 17 (0.8 g) as an oil: IR (CHCl3) (2RS,3R,5R)-5-(12-Methyltridecyl)tetrahydrofuran-2,3-diol (18) To a solution of 17 (370 mg) in dioxane (4.2 ml) was added H2O (1.2 ml) and 1 N HCl (0.6 ml). The mixture was stirred at 70°C for 2 hours and then neutralized with 1 N NaOH. The resulting mixture was coned to dryness in vacuo to give a residue, which was diluted with H,O and extracted with CHCl3. The extract was dried over MgSO4, evaporated to dryness to leave an oil, which was purified by preparative TLC, developed with MeOH -CHCl3 (1: 9) to afford 18 (300 mg) as an oil: IR (CHCl3) 3400, 2920 , 2850 , 1460 , 1380 , 1360 , 1020 (CDCl3) 
15-Methyl-3(R)-hydroxyhexadecanal (19)
To a stirred solution of 18 (370 mg) in dioxane (10 ml) was added a solution of NaIO, (1.3 g) in H2O (2 ml), and the mixture was stirred at room temp for 2 hours under argon atmosphere. The reaction mixture was coned to dryness in vacuo to leave a residue, to which H2O was added. The mixture was extracted with CHCl3, and extract was washed with brine, dried over MgSO4 and then evaporated to give crude 19 (300 mg) as an oil: IR (CHCl3) 3400, 2920 , 2850 , 2720 , 1715 , 1460 , 1380 , 1360 , 1180 El-MS m/z 270 (M+) .
15-Methyl-3(R)-hydroxyhexadecanoic Acid (20)
To a stirred solution of 19 (300 mg) and catalytic amount of P-TsOH • H2O in anhydrous dioxane (4 ml) was added dihydropyran (1 ml) and the mixture was stirred at ambient temp for 1 hour under argon atmosphere. Removal of the solvent in vacuo left an oil, which was dissolved in ether. The solution was washed with 5 % NaHCO3, brine, dried over MgSO4, and then evaporated to give crude 15-methyl-3(R)-tetrahydropyranyloxyhexadecanol (310 mg) as an oil, which was dissolved in EtOH (4 ml). To this solution were added a solution of AgNO3 (830 mg) in H2O (0.8 ml) and a solution of KOH (1.3 g) in H2O (2 ml). The heterogeneous mixture was stirred at room temp for 4 hours under argon atmosphere. The reaction mixture was diluted with H20 and extracted with ether. The residual aqueous solution was acidified with 5 % citric acid and extracted with CHCl3. The chloroform solution was washed with brine, dried over MgSO4 and evaporated to leave an oil, which was purified by preparative TLC on silica gel, developed with MeOH -CHCl3 To a solution of 20 (107 mg) and N-hydroxysuccinimide (48 mg) in a mixture of dioxane (2 ml) and EtOAc (2 ml), was added a solution of dicyclohexylcarbodiimide (78 mg) in EtOAc (0.5 ml) at 0°C. The mixture was stirred at room temp overnight, and the solvent was removed in vacuo to leave an oil, which was dissolved in EtOAc. The insoluble residue was filtered off, and the filtrate was washed with H2O, brine and dried over MgSO,. The EtOAc solution was evaporated to give a residue, which was treated with ether -EtOAc (1: 1). The insoluble residue was removed by filtration and the filtrate was evaporated in vacuo to afford 15-methyl-3(R)-hydroxyhexadecanoic acid succinimide ester (142 mg) as an oil: IR (CHCl3) 3500, 2920, 2850, 1820, 1780, 1730, 1460, 1360, 1060 Benzyl N-(15-Methyl-3(R)-hydroxyhexadecanoyl)glycinate (21) To a suspension of glycine benzyl ester p-toluenesulfonic acid salt (195 mg) in THE (2 ml) was added triethylamine (81 pl), and the mixture was stirred at room temp for 30 minutes. To this solution was added a solution of 15-methyl-3(R)-hydroxyhexadecanoic acid succinimide ester (74 mg) in THE (1 ml). The resulting solution was stirred at room temp for 2 hours, and then the solvent was removed in vacuo to leave a residue, which was dissolved in EtOAc. The EtOAc solution was washed with 1 N HCl, 5 % Na2CO3, brine, and dried over MgSO,. Removal of the solvent to dryness to afford 21 (80 mg) as an oil: IR (CHCl3) 3400, 2920, 2850, 1730, 1660, 1520, 1380, 1080 (10-Carboxydecyl)triphenylphosphonium Bromide A mixture of 11-bromoundecanoic acid (13.3 g) and triphenylphosphine (13 g) was stirred at 85°C for 1 hour. After cooled, the resulting solid was dissolved in a hot solution of CHCl3 -EtOH (20: 1). To the cooled mixture was added ether and the precipitate was collected by filtration. After this operation was repeated twice, the resulting powder was dried up by using vacuum pump to give (10-carboxydecyl)triphenylphosphonium bromide (24 g) as a powder: IR (Nujol) 3480, 3250, 1700, 1440, 1110, 760, 740, 720 cm-1. 13-Methyl-I 1-tetradecenoic Acid (10-Carboxydecyl)triphenylphosphonium bromide (6.85 g) and redistilled isobutyraldehyde (1.3 g) were dissolved in a mixture of dry THE (26 ml) and dry DMSO (34 ml). The resulting solution was added over a period of 45 seconds to NaH (1.3 g, from which the mineral oil had been previously removed) at 0-5'C under a nitrogen atmosphere. After being stirred for 2 hours at 5-10°C and then for 20 hours at room temp, the mixture was diluted with H2O, acidified to pH 3 with 30 % phosphoric acid, and extracted with n-hexane. The hexane extract was coned to an oil, taken up in benzene and extracted with 5 % NaOH and the alkali washings were combined and washed with benzene. After acidification with 30% phosphoric acid, the mixture was extracted with ether and the ethereal extract was washed with H2O, dried over MgSO4, and evaporated to give the cis, traps mixture of 13-methyl-11-tetradecenoic acid (1.75 g) as an oil: IR (film) 3600 2400, 2940, 2870, 1710 cm-1; NMR (CDCl3) 13-Methyltetradecanoic Acids A solution of 13-methyl-1 l-tetradecenoic acid (1 g) in EtOH (30 ml) was hydrogenated over Pd-black (200 mg) under H2 at 3.5 4.0 atm for 3 hours. After removal of the catalyst by filtration, the filtrate was evaporated to give 13-methyltetradecanoic acid (0.85 g), which was crystallized from acetone: mp 53°C; IR (KBr) 2920, 2850, 1700, 1465, 1430, 1405 cm-1; FD-MS m/z 243 (M++1).
Methyl 13-Methyltetradecanoate To a solution of 13-methyltetradecanoic acid (100 mg) in MeOH (5 ml) was added an ethereal solution of excess diazomethane. The resulting solution was kept in a refrigerator overnight and then
